drugset / Trial / NCT01530386

A Multicenter, Open-label Study to Determine the Effects of Lacosamide on Sleep in Healthy Subjects

NCT01530386

Phase 1 Completed 25 enrolled UCB Pharma
NaSingle-groupOpen-label

Summary

The effects of Lacosamide, an antiepileptic drug, on sleep have not been formally evaluated. The present study is being conducted to assess the effects of Lacosamide on sleep quality in healthy subjects.

Timeline

Start
2012-01
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Lacosamide Other / unclassified 300 mg Oral

Indications

No indication recorded.